Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Health News Nevada.
Press releases published on April 29, 2025
Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results
GlobeNewswire
·
April 29, 2025
SOMERSET, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Tuesday, May 13, 2025, to review first-quarter 2025 …
Pacira to Report First Quarter 2025 Financial Results on Thursday May 8, 2025
GlobeNewswire
·
April 29, 2025
BRISBANE, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will report its …
Kestra Showcases Real-World Outcomes for ASSURE WCD at Heart Rhythm 2025
GlobeNewswire
·
April 29, 2025
KIRKLAND, Wash., April 29, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) (“Kestra”), a wearable medical device and digital healthcare company, today announced the presentation of new real-world data on the ASSURE® Wearable …
Integer to Present at Bank of America Securities Health Care Conference on May 14
GlobeNewswire
·
April 29, 2025
PLANO, Texas, April 29, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), today announced participation in the 2025 Bank of America Securities Health …
iCAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft’s Precision Imaging Network (PIN)
GlobeNewswire
·
April 29, 2025
NASHUA, N.H., April 29, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”), a global leader in clinically proven AI-powered cancer detection solutions, announced today a collaboration with Microsoft, to include a set of AI-powered …
Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025
GlobeNewswire
·
April 29, 2025
WILMETTE, Ill., April 29, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, today announced that data on the long …
Commure and HealthTap Partner to Deliver Seamless, Unified Virtual and In-Person Care
GlobeNewswire
·
April 29, 2025
SAN FRANCISCO, April 29, 2025 (GLOBE NEWSWIRE) -- Commure, a leader in health technology infrastructure, today announced a strategic partnership with virtual care innovator HealthTap to launch a unified healthcare solution that bridges the gap between in- …
aTyr Pharma Presents Preclinical Data for NRP2-Targeting Antibody ATYR2810 at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire
·
April 29, 2025
SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase …
Nautilus Biotechnology Reports First Quarter 2025 Financial Results
GlobeNewswire
·
April 29, 2025
SEATTLE, April 29, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2025. “In Q1, …
Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors
GlobeNewswire
·
April 29, 2025
WALTHAM, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
OneMedNet’s regulatory-grade imaging Real-World Data (iRWD) now available in HealthVerity Marketplace™
GlobeNewswire
·
April 29, 2025
MINNEAPOLIS, April 29, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), the leading provider of regulatory-grade imaging Real-World Data (iRWD), today announced that its iRWD solution is now available in HealthVerity Marketplace™, enabling …
Madrigal to Present Late-Breaking Resmetirom Data in Patients with Compensated MASH Cirrhosis at the EASL Congress
GlobeNewswire
·
April 29, 2025
CONSHOHOCKEN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced six …
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald
GlobeNewswire
·
April 29, 2025
WARREN, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today reminds that CEO Dr. Ryan Saadi MD, MPH will participate in BioNJ’s Fifteenth Annual Bio Partnering Conference. Dr. Saadi will be …
Belite Bio Announces Poster Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting
GlobeNewswire
·
April 29, 2025
SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical …
ZyVersa Therapeutics Announces Published Data Showing Inflammasome ASC Inhibitor IC 100 Decreases Microglial Inflammasome Activation and Alpha-Synuclein That Contribute to Neurodegeneration in Parkinson’s Disease
GlobeNewswire
·
April 29, 2025
Study supported by the Michael J. Fox Foundation through a grant awarded to ZyVersa and leading inflammasome experts at University of Miami Miller School of Medicine who conducted the study. Parkinson’s Disease (PD) affects over 10 million people globally …
Aurora Spine Corporation Announces Fourth Quarter and Fiscal Year 2024 Financial Results
GlobeNewswire
·
April 29, 2025
-Company reports record revenue of $17.6 million for FY 2024, an increase of 21% – -Company to host conference call Today, Tuesday, April 29th at 11am ET/8am PT – NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif …
Die Olon Group festigt ihre Führungsposition im Bereich Bioproduktion durch zwei strategische Ernennungen in Frankreich
GlobeNewswire
·
April 29, 2025
MAILAND, April 29, 2025 (GLOBE NEWSWIRE) -- Die Olon Group, ein weltweit führender CDMO-Anbieter im Pharmabereich, gibt die Ernennung von Jérôme Bédier zum CEO seiner französischen Unternehmen und von Andrea Conforto zum M…
Olon Group renforce son leadership dans la bioproduction avec deux nominations stratégiques en France
GlobeNewswire
·
April 29, 2025
MILAN, 29 avr. 2025 (GLOBE NEWSWIRE) -- Olon Group, acteur mondial de référence dans les services CDMO pharmaceutiques, annonce la nomination de Jérôme Bédier comme PDG de ses entités françaises, et d’Andrea Conforto comme vice-président M…
オロングループ (Olon Group) 、フランスにおける2件の戦略的な任命によりバイオ生産分野でのリーダーシップを強化
GlobeNewswire
·
April 29, 2025
ミラノ発, April 29, 2025 (GLOBE NEWSWIRE) -- 世界有数の製薬CDMOであるオロングループは、フランス法人のCEOにジェローム・ベディエ (Jérôme Bédier) を、バイオ医薬品向けCDMOサービスに特化した部門であるオロン・バイオテック (Olon Biotech) のM…
Olon Group, 프랑스 법인 통해 두 명의 전략적 임원 선임으로 바이오 생산 분야 리더십 강화에 나서
GlobeNewswire
·
April 29, 2025
밀라노, April 29, 2025 (GLOBE NEWSWIRE) -- 글로벌 제약 CDMO (위탁개발생산) 기업인 Olon Group이 프랑스 법인의 CEO로 Jérôme Bédier를, 생물학적 제제 CDMO 서비스 전담 사업부인 Olon Biotech의 M…